uniQure (QURE) Other Non-Current Liabilities (2015 - 2026)
uniQure's (QURE) quarterly Other Non-Current Liabilities came in at $2.7 million in Q1 2026, down 78.75% year-on-year from $12.6 million in Q1 2025, and down 85.71% quarter-over-quarter from $18.7 million in Q4 2025.
uniQure (QURE) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
uniQure's Other Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 78.75% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 78.75% decrease from a year earlier, with the FY2025 full-year figure at $18.7 million, up 135.91% from the prior year.
- Other Non-Current Liabilities declined to $2.7 million in Q1 2026 per QURE's latest filing, from $18.7 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $41.4 million in Q3 2024 and bottomed at $935000.0 in Q4 2022.
- The 5-year median for Other Non-Current Liabilities is $7.9 million (2024), against an average of $12.1 million.
- Across the five-year window, Other Non-Current Liabilities jumped 3687.74% in 2024 and slumped 86.61% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $935000.0 in 2022, then jumped by 1482.35% to $14.8 million in 2023, then tumbled by 46.32% to $7.9 million in 2024, then surged by 135.91% to $18.7 million in 2025, then sank by 85.71% to $2.7 million in 2026.
- Per Business Quant, the three latest QURE Other Non-Current Liabilities figures stand at $2.7 million (Q1 2026), $18.7 million (Q4 2025), and $5.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 18.74 Mn |
| Sep 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 15.93 Mn |
| Mar 31, 2025 | 12.60 Mn |
| Dec 31, 2024 | 7.94 Mn |
| Sep 30, 2024 | 41.40 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 14.63 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 960,000.00 |
| Mar 31, 2023 | 36.90 Mn |
| Dec 31, 2022 | 935,000.00 |
| Sep 30, 2022 | 3.05 Mn |
| Jun 30, 2022 | 3.49 Mn |
| Mar 31, 2022 | 22.06 Mn |
| Dec 31, 2021 | 4.24 Mn |
| Sep 30, 2021 | 3.81 Mn |
| Jun 30, 2021 | 3.25 Mn |